Series C funding round for Tarveda Therapeutics raising $38M in January 2016
Series C funding round for Tarveda Therapeutics raising $38M in January 2016
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$92M
Top Valuation
-
Tarveda Therapeutics raised $38M in a Series C round.
The round was announced on 01/01/16.